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IMMUNOASSAYS POR THE DETERMINATION OF HUMAN TISSUE KALLIKREIN 
(TK) IN DIFFERENT BODY FLUIDS BASED O N MONOCLONAL ANTIBODIES 
K. Witzgall, G. Godec, K. Shimamoto* and E. Fink 
Department of C l i n i c a l Chemistry and C l i n i c a l Biochemistry, 
university of Munich, Nussbaumstr. 20, D-8000 Munich 2, Germany 
and *2 n d Department of Internal Medicine, Sapporo Medical 
College S-l W-16 Chuo-ku, Sapporo 060, Japan 
SUMMARY: A monoclonal antibody produced against human ti s s u e k a l -
l i k r e i n was used to develop s o l i d phase immunoassays for the de-
termination of t o t a l immunoreactive tissue k a l l i k r e i n , of the com-
plex of t i s s u e k a l l i k r e i n with cr^-proteinase i n h i b i t o r , and of 
enzymatically active tissue k a l l i k r e i n . The assays permit the spe-
c i f i c determination of various forms of tissue k a l l i k r e i n i n body 
f l u i d s and should be very useful i n studies on the b i o l o g i c a l 
function of tiss u e k a l l i k r e i n - k i n i n systems. 
INTRODUCTION 
The determination of ti s s u e k a l l i k r e i n (TK) i n body f l u i d s 
and tissues can be achieved by a number of methods, e. g. rad i o -
immunoassays, enzyme immunoassays, determination of k i n i n - r e l e a s -
ing a c t i v i t y , or hydrolysis of synthetic substrates. Due to the 
fact that TK i s present i n the organism i n d i f f e r e n t forms, such 
as enzymatically inactive proenzyme, active TK or complexes with 
i n h i b i t o r s , no single assay technique alone can accomplish the 
s p e c i f i c q u a n t i f i c a t i o n of each of the TK species. 
Here we present assays which are based on a monoclonal a n t i -
body for capturing the TK antigen and various detection systems 
permitting the s p e c i f i c determination of diff e r e n t forms of TK. 
MATERIALS AND METHODS 
Materials 
Human urinary k a l l i k r e i n (HUK) isola t e d according to (1) and rab-
b i t polyclonal antibodies to HUK were g i f t s of Dr. R. Geiger (Me-
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dor, Herrsching, Germany). Polyclonal antibodies to human (^-pro-
teinase i n h i b i t o r (a 1PI): Calbiochem, Frankfurt, Germany; alka-
l i n e phosphatase labeled anti - r a b b i t IgG: BioRad, Munich, Germa-
ny; substrate for k a l l i k r e i n : H-D-ValLeuArg-p-nitroanilide (S-
2266): KABI, Freiburg, Germany. Microplate reader MR 700: Dyna-
tech, Denkendorf, Germany. 
Buffers. A: 0.015 M sodium carbonate, 0.035 M sodium bic a r -
bonate, pH 9.6; 
B: 0.01 M monosodium phosphate, 0.15 M sodium chloride, pH 7.4; 
C: 25 g/1 casein i n buffer B; 
D: 20 g/1 bovine serum albumin, 0.5 ml/1 Tween 20 i n buffer A; 
E: 0.01 M monosodium phosphate, 0.14 M sodium chloride, 0.03 M 
EDTA, 3 mM o-phenanthroline, pH 7.4; 
F: 0.01 M monosodium phosphate, 0.14 sodium chloride, 0.03 M 
EDTA, 3 mM o-phenanthroline, 0.5 g sodium azide/1, 0.2 g thimero-
sal/1, 0.4 ml Tween 20/1, pH 7.4; 
G: 1.0 M diethanolamine/HCl, 100 mg/1 MgCl 2*6 H20, pH 9.6. 
Standards. The protein concentration of a stock solution of 
highly p u r i f i e d human urinary k a l l i k r e i n was determined by amino 
acid analysis. Standard solutions of TK were prepared by d i l u t i n g 
the stock solution appropriately. A stock solution of TK-a 1PI was 
prepared by incubating an aliquot of the TK stock solution with 
an excess of a 1PI for 24 h at room temperature. 
Murine monoclonal antibodies against human tissue k a l l i k r e i n 
were developed using human urinary k a l l i k r e i n (1) as antigen by 
employing conventional hybridoma techniques. Antibodies of s i x 
d i f f e r e n t clones were produced, i s o l a t e d and characterized, one 
of them was used for the immunoassays. 
Coating of s o l i d phase with monoclonal antibody. The wells 
of mi c r o t i t e r plates (Immunolon F, Dynatech, Denkendorf, Germany) 
were coated with monoclonal antibody by incubation (16 h, 4 -C) 
with 0.2 ml of a solution containing 3 p g / m l monoclonal antibody 
in buffer A. After washing the plate s i x times with 30 ml buffer 
B the remaining protein-binding s i t e s i n each well were blocked 
by incubation with buffer C for 1 h. A f t e r removing the buffer 
the plate was ready for use. 
Capturing of immunoreactive TK. 0.2 ml of TK standard solu-
tions or unknown samples containing TK and/or TK-o^PI, di l u t e d i n 
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buffer D, were pipetted into the wells, then the m i c r o t i t e r plate 
was incubated f o r 2 h at 37 *C and washed. 
Determination of captured antigen by second antibody. For 
the determination of t o t a l immunoreactive TK 0.2 ml of a solution 
of a rabbit anti-TK antibody, 1 /ig/ml i n buffer D, was added, the 
plate was incubated for 2 h at 37 *C and washed. Then 0.2 ml of 
a l k a l i n e phosphatase labeled a n t i - r a b b i t IgG (diluted 1:3000 i n 
buffer D) was pipetted into each well. After washing 0.2 ml 4-
nitrophenylphosphate, 1-2 g/1 in buffer G was added and a f t e r 10-
30 min incubation at 37 *C the absorbance at 405 nm was read. The 
complex of TK with a 1-proteinase i n h i b i t o r (TK-o^PI) captured by 
the monoclonal antibody was determined by the same technique but 
using as second antibody a rabbit antiserum to o^PI d i l u t e d 
1:3000 with buffer D. 
Determination of captured enzvroaticallv active t i s s u e k a l -
l i k r e i n with a synthetic substrate. After the capturing step 
0.2 ml of f r e s h l y prepared substrate solution, 0.4 mM H-D-Val-
Leu-Arg-p-nitroanilide in 0.01 M T r i s , pH 8.2 were pipetted into 
each well. A f t e r 24 h incubation at 37 *C absorbance at 405 nm 
was read using the microplate reader. 
Determination of captured enzymatically active t i s s u e k a l -
l i k r e i n with kininogen as substrate. Into each well with TK bound 
to the coating monoclonal antibody 0.2 ml of a solution of dog 
kininogen (Marin-Grez and Carretero, 1972), 2 mg/ml i n buffer E, 
was pipetted. A f t e r 4 h at 37 *C 0.1 ml of the solution was r e -
moved and mixed with 1.0 ml ethanol, the mixture was centrifuged 
for 10 min at 10,000 x g and 1.0 ml of the supernatant was dried 
i n a SpeedVac concentrator. The dry residue was dissolved i n buf-
fer F and the k i n i n was determined by radioimmunoassay (2). 
RESULTS AND DISCUSSION 
A system of assays based on one monoclonal antibody was de-
veloped by which various forms of t i s s u e k a l l i k r e i n present i n 
body f l u i d s can be determined. 
The antibody i s bound to a s o l i d phase and captures the TK 
present i n the sample. By using d i f f e r e n t detection systems d i f -
ferent species of TK, i . e. t o t a l (= free + complexed) t i s s u e 
k a l l i k r e i n , the complex of the enzyme with o^-proteinase i n h i b i -
tor and enzymatically active TK can. be determined. Total TK and 
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the TK-o^PI complex captured by the monoclonal antibody are de-
tected using polyclonal antibodies to TK and o^PI, respectively 
as second antibody in a sandwich ELISA. 
Enzymatically active TK captured by the monoclonal antibody 
was determined either by using the synthetic substrate H-D-Val-
Leu-Arg-p-nitroanilide or by incubation with kininogen and subse-
quent measuring of released k i n i n by a radioimmunoassay. 
The lower levels of detection and the in t e r - and intraassay 
c o e f f i c i e n t s of variation are given i n Table 1 for a l l assay sys-
tems. The a c t i v i t y determination with S-2266 as substrate i s by a 
factor of 25-50 less s e n s i t i v e then the other assays. However, 
speed and/or s e n s i t i v i t y of t h i s assay can be improved by employ-
ing fluorimetrie substrates. 
Total TK TK-o^PI Acti\ 
Kininogen 
re TK 
S-2266 
Lower l i m i t 
of detection 
0.2 ng/ml 0.2 ng/ml 0.1 ng/ml 5.0 ng/ml 
Intraassay 
v a r i a t i o n 
3.3 % 4.8 % 13.1 % 4.4 % 
Interassay 
v a r i a t i o n 
5.2 % 11.6 % 16.4 % 6.7 % 
Table 1. Lower levels of detection and i n t r a - and interassay 
c o e f f i c i e n t s of v a r i a t i o n . Values for TK-o^PI con-
centrations represent concentrations of the TK bound to 
crjPI. 
The recovery of tissue k a l l i k r e i n added to samples of b i o l o g i c a l 
f l u i d s ( f i n a l concentrations: 2 ng/ml; for the assay with S-2266: 
10 ng/ml) was between 92 and 99 % for urine, seminal plasma and 
s a l i v a . The recovery in serum of t o t a l TK and of the complex of 
TK with a^PI was 79-81 %. Recovery of active TK i n serum was i n 
the range of only 40 % r e f l e c t i n g the inactivation of the added 
tissue k a l l i k r e i n by complex formation with a 1PI and possibly 
other plasmatic i n h i b i t o r s . 
The assays were successfully employed to determine the concentra-
tions of the various tissue k a l l i k r e i n species i n human serum, 
urine, seminal plasma and s a l i v a (Table 2). In a l l the f l u i d s the 
concentrations of a l l TK species varied over a wide range. The 
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lowest concentrations of t o t a l TK were found i n serum and v i r t u -
a l l y a l l of the TK was complexed with o^PI, enzymatically active 
k a l l i k r e i n could not be detected. In the in d i v i d u a l urine samples 
the concentrations of t o t a l and enzymatically active TK d i f f e r e d 
by up to 75 %. This difference could not be explained by the pre-
sence of TK-a 1PI since t h i s was found at low concentrations only. 
The difference was obviously due to the presence of high portions 
of. t i s s u e p r o k a l l i k r e i n in urine as i t disappeared when the urine 
samples were treated with trypsin pri o r to the a c t i v i t y assay 
(data not shown). 
Total TK 
[ng/ml] 
TK-a^PI 
[ng/ml] 
Actrv 
Kininogen 
[ng/ml] 
re TK 
S-2266 
[ng/ml] 
Serum 
(n - 10) 
0.2 - 2.2 0.2 - 2.0 n.d. n.d. 
Urine 
(n = 5) 
195 - 558 4 - 3 2 56 - 212 71 - 210 
Seminal 
plasma 
(n = 20) 
13 - 201 1 - 3 2 3 - 204 n.d. - 188 
Sal i v a 
(n = 5) 
1141 - 6116 44 - 1043 798 - 5183 1129 - 5351 
Table 2. Contents of t o t a l TK, TK-a^PI and acti v e TK i n human 
serum, urine, seminal plasma and s a l i v a . 
Values for TK-o^PI concentrations represent concentra-
tions of the TK bound to a,PI; n.d. = not detectable. 
CONCLUSION 
The assay system described here i s highly s u i t a b l e f o r the spe-
c i f i c determination of d i f f e r e n t forms of human t i s s u e k a l l i k r e i n 
i n body f l u i d s . In addition, i t can be e a s i l y adapted to the de-
termination of complexes of TK with proteins other than a 1PI, 
such as k a l l i k r e i n binding protein (3) or protein C i n h i b i t o r 
(4), by employing as second antibody a s p e c i f i c antibody directed 
towards the respective complex-forming protein. 
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